Your Brand just got added to a must-have payer formulary, now what?
Watch it now (or any time)
Hear directly from the experts!
In the current industry landscape, pharma marketers cannot depend on sales representatives alone to drive prescriptions after a formulary win. What does this mean for you and your brand?
Join this webinar to learn:
- The ways in which "business as usual" has been redefined, and what this means going forward
- How prescriber attitudes towards technology continue to shift
- The most efficient ways to reach your target audience right now
Featuring a conversation with:
Director, Media - CMI Media Group
Candice has worked across multiple therapeutic categories, representing some of pharma’s largest companies. Over the last 15 years, her experience spans from strategic planning to digital investment to programmatic execution—across DTC and HCP campaigns, as well as non-pharma verticals including retail and energy. Candice has devoted her career to ensuring an optimal doctor-patient experience by taking a holistic approach to marketing. Her laser focus on the ever-evolving POC and EHR landscape has delivered proven results by ensuring the right information gets to the right people at the most crucial time in the treatment journey. Candice has been honored with awards from Advertising Women of New York, Adweek, OMMA and Digiday.
Senior Vice President, Business Strategy at Entree Health
Jim Massa brings almost 30 years of market access and pull-thru experience to our panel discussion today.
Jim spent over 25 years at Pfizer as an award winning sales manager, account manager and team leader. Most recently he was the Payer Strategy and Channel Lead for Upjohn, North America , a division of Pfizer. During his time at Pfizer, Jim led the market access strategy and execution with many products across the entire product life cycle including launching a rare disease injectable agent and Pfizer's first oral oncology product. Additionally, Jim led numerous B2B payer and channel initiatives with over 10 post LOE assets.
Jim is currently Senior Vice President, Business Strategy at Entree Health. In this role, Jim has been working with over a dozen large and small biopharma companies helping brands secure market access for patients.